Hyperfine Inc./$HYPR
1D1W1MYTD1Y5YMAX
About Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.
- Ticker
- $HYPR
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 102
- Headquarters
- Guilford, United States
- Website
- www.hyperfinemri.com
Hyperfine Inc. Metrics
BasicAdvanced
$88M
-
-$0.38
1.43
-
Price and volume
Market cap
$88M
Beta
1.43
52-week high
$2.22
52-week low
$0.83
Average daily volume
579K
Financial strength
Current ratio
6.152
Quick ratio
5.114
Long term debt to equity
36.006
Total debt to equity
36.49
Interest coverage (TTM)
-54.57%
Profitability
EBITDA (TTM)
-32.499
Gross margin (TTM)
51.41%
Net profit margin (TTM)
-210.75%
Operating margin (TTM)
-203.27%
Revenue per employee (TTM)
$160,000
Management effectiveness
Return on assets (TTM)
-38.82%
Return on equity (TTM)
-96.97%
Valuation
Price to revenue (TTM)
4.672
Price to book
2.4
Price to tangible book (TTM)
2.4
Price to free cash flow (TTM)
-2.806
Free cash flow yield (TTM)
-35.63%
Free cash flow per share (TTM)
-0.297
Growth
Revenue change (TTM)
53.16%
Earnings per share change (TTM)
-28.50%
3-year revenue growth (CAGR)
19.10%
3-year earnings per share growth (CAGR)
-18.43%
Hyperfine Inc. News
AllArticlesVideos

Hyperfine Q2 Earnings Call Highlights
MarketBeat3 weeks ago

Hyperfine Announces the Release of Multiple Peer-Reviewed Publications, Expanding Clinical Evidence for the Swoop® System Across a Growing Number of Sites of Care
Business Wire1 month ago

Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026
Business Wire1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.